{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T09:44:39Z","timestamp":1792748679521,"version":"4.5.0"},"reference-count":30,"publisher":"American Chemical Society (ACS)","issue":"20","license":[{"start":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:00:00Z","timestamp":1791590400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:00:00Z","timestamp":1791590400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:00:00Z","timestamp":1791590400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai Municipality","doi-asserted-by":"publisher","award":["24ZR1413200"],"award-info":[{"award-number":["24ZR1413200"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2025M772413"],"award-info":[{"award-number":["2025M772413"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["12275057"],"award-info":[{"award-number":["12275057"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U23A20465"],"award-info":[{"award-number":["U23A20465"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Nuclear Technology Research and Development Program","award":["HNKFHBZ202319(36)"],"award-info":[{"award-number":["HNKFHBZ202319(36)"]}]},{"name":"Shanghai Oriental Talents Program Youth Project","award":["SSF828085"],"award-info":[{"award-number":["SSF828085"]}]},{"name":"Shanghai Collaborative Innovation Project","award":["HCXBCY-2024-001"],"award-info":[{"award-number":["HCXBCY-2024-001"]}]},{"name":"Shanghai Collaborative Innovation Project","award":["XTCX-CY-2025-017"],"award-info":[{"award-number":["XTCX-CY-2025-017"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The HER2-targeted nanobody NB46 was evaluated for labeling strategy flexibility and thermostability. Random and site-specific 68Ga labeling strategies were compared. Both conjugates exhibited high HER2 affinity, comparable to unmodified NB46. Cellular uptake, pharmacokinetics, micro-PET\/CT imaging, and biodistribution in HER2-positive and HER2-negative tumor-bearing mice revealed no significant differences between the two strategies. NB46 retained HER2 affinity at temperatures up to 90 \u00b0C, demonstrating exceptional thermostability. Both conjugates achieved &amp;gt;95% radiochemical yields at all tested temperatures. Micro-PET\/CT imaging showed sustained high tumor uptake with renal clearance as the primary elimination pathway. Blocking studies confirmed that NB46 and trastuzumab competitively bind to HER2. Elevated labeling temperatures did not compromise tumor targeting but resulted in a mild increase in renal uptake, notably for the random conjugate at 90 \u00b0C. These findings suggest that random labeling may represent a simpler, equally effective alternative for 68Ga-NB46 preparation, and confirm the excellent thermostability of this nanobody scaffold.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.6c02664","type":"journal-article","created":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:01:28Z","timestamp":1791651688000},"page":"24827-24837","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of 68Ga Labeling Strategies and Thermostability of HER2-Targeted Nanobody NB46"],"prefix":"10.1021","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4270-5335","authenticated-orcid":true,"given":"Lingzhou","family":"Zhao","sequence":"first","affiliation":[{"name":"Fudan University Shanghai Cancer Center , , ,","place":["Shanghai, China, 200032"]},{"name":"Fudan University , , ,","place":["Shanghai, China, 200032"]},{"name":"Fudan University , , ,","place":["Shanghai, China, 200032"]},{"name":"Shanghai Engineering Research Center of Molecular Imaging Probes , ,","place":["Shanghai, China, 200032"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyan","family":"Bai","sequence":"additional","affiliation":[{"name":"Fudan University Shanghai Cancer Center , , ,","place":["Shanghai, China, 200032"]},{"name":"Fudan University , , ,","place":["Shanghai, China, 200032"]},{"name":"Fudan University , , ,","place":["Shanghai, China, 200032"]},{"name":"Shanghai Engineering Research Center of Molecular Imaging Probes , ,","place":["Shanghai, China, 200032"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamin","family":"Zhu","sequence":"additional","affiliation":[{"name":"Fudan University Shanghai Cancer Center , , ,","place":["Shanghai, China, 200032"]},{"name":"Fudan University , , ,","place":["Shanghai, China, 200032"]},{"name":"Fudan University , , ,","place":["Shanghai, China, 200032"]},{"name":"Shanghai Engineering Research Center of Molecular Imaging Probes , ,","place":["Shanghai, China, 200032"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Sun","sequence":"additional","affiliation":[{"name":"Fudan University Shanghai Cancer Center , , ,","place":["Shanghai, China, 200032"]},{"name":"Fudan University , , ,","place":["Shanghai, China, 200032"]},{"name":"Fudan University , , ,","place":["Shanghai, China, 200032"]},{"name":"Shanghai Engineering Research Center of Molecular Imaging Probes , ,","place":["Shanghai, China, 200032"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Liu","sequence":"additional","affiliation":[{"name":"Fudan University Shanghai Cancer Center , , ,","place":["Shanghai, China, 200032"]},{"name":"Fudan University , , ,","place":["Shanghai, China, 200032"]},{"name":"Fudan University , , ,","place":["Shanghai, China, 200032"]},{"name":"Shanghai Engineering Research Center of Molecular Imaging Probes , ,","place":["Shanghai, China, 200032"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Lu","sequence":"additional","affiliation":[{"name":"Fudan University Shanghai Cancer Center , , ,","place":["Shanghai, China, 200032"]},{"name":"Fudan University , , ,","place":["Shanghai, China, 200032"]},{"name":"Fudan University , , ,","place":["Shanghai, China, 200032"]},{"name":"Shanghai Engineering Research Center of Molecular Imaging Probes , ,","place":["Shanghai, China, 200032"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Zhang","sequence":"additional","affiliation":[{"name":"Fudan University Shanghai Cancer Center , , ,","place":["Shanghai, China, 200032"]},{"name":"Fudan University , , ,","place":["Shanghai, China, 200032"]},{"name":"Fudan University , , ,","place":["Shanghai, China, 200032"]},{"name":"Shanghai Engineering Research Center of Molecular Imaging Probes , ,","place":["Shanghai, China, 200032"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Xu","sequence":"additional","affiliation":[{"name":"Fudan University Shanghai Cancer Center , , ,","place":["Shanghai, China, 200032"]},{"name":"Fudan University , , ,","place":["Shanghai, China, 200032"]},{"name":"Fudan University , , ,","place":["Shanghai, China, 200032"]},{"name":"Shanghai Engineering Research Center of Molecular Imaging Probes , ,","place":["Shanghai, China, 200032"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2544-7522","authenticated-orcid":true,"given":"Shaoli","family":"Song","sequence":"additional","affiliation":[{"name":"Fudan University Shanghai Cancer Center , , ,","place":["Shanghai, China, 200032"]},{"name":"Fudan University , , ,","place":["Shanghai, China, 200032"]},{"name":"Fudan University , , ,","place":["Shanghai, China, 200032"]},{"name":"Shanghai Engineering Research Center of Molecular Imaging Probes , ,","place":["Shanghai, China, 200032"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,10,10]]},"reference":[{"key":"2026102305073254200_cit1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40364-024-00565-1","article-title":"HER2-targeted therapies in cancer: a systematic review","volume":"12","author":"Zhu","year":"2024","journal-title":"Biomark Res"},{"key":"2026102305073254200_cit2","doi-asserted-by":"publisher","first-page":"700","DOI":"10.2967\/jnumed.123.266847","article-title":"Human Epidermal Growth Factor Receptor 2 (HER2) PET Imaging of HER2-Low Breast Cancer with [68Ga]Ga-ABY-025: Results from a Pilot Study","volume":"65","author":"Altena","year":"2024","journal-title":"J Nucl Med"},{"key":"2026102305073254200_cit3","doi-asserted-by":"publisher","first-page":"112961","DOI":"10.1016\/j.ejrad.2026.112961","article-title":"HER2-targeted PET\/CT in breast cancer: a systematic review of lesion-level concordance with pathology","volume":"202","author":"Bure\u0301n","year":"2026","journal-title":"Eur J Radiol"},{"key":"2026102305073254200_cit4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41698-025-01209-9","article-title":"HER2 expression in breast cancer: evidence gaps and challenges","volume":"10","author":"Atallah","year":"2025","journal-title":"NPJ Precis Oncol"},{"key":"2026102305073254200_cit5","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1056\/nejmoa1914510","article-title":"Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer","volume":"382","author":"Modi","year":"2020","journal-title":"N Engl J Med"},{"key":"2026102305073254200_cit6","doi-asserted-by":"publisher","first-page":"1144817","DOI":"10.3389\/fmolb.2023.1144817","article-title":"Molecular imaging of HER2 receptor: Targeting HER2 for imaging and therapy in nuclear medicine","volume":"10","author":"Miladinova","year":"2023","journal-title":"Front Mol Biosci"},{"key":"2026102305073254200_cit7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13058-020-1252-7","article-title":"HER2 heterogeneity and resistance to anti-HER2 antibody-drug conjugates","volume":"22","author":"Ocan\u0303a","year":"2020","journal-title":"Breast Cancer Res"},{"key":"2026102305073254200_cit8","doi-asserted-by":"publisher","first-page":"12089","DOI":"10.1097\/js9.0000000000004829","article-title":"HER2-targeted molecular probes for cancer imaging: construction, optimization, and clinical applications","volume":"112","author":"Guo","year":"2026","journal-title":"Int J Surg"},{"key":"2026102305073254200_cit9","doi-asserted-by":"publisher","first-page":"100009","DOI":"10.1016\/j.mmr.2026.100009","article-title":"Nanobodies in biomedicine: from molecular characteristics to fabrication and clinical translation","volume":"13","author":"Cao","year":"2026","journal-title":"Mil Med Res"},{"key":"2026102305073254200_cit10","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1146\/annurev-biochem-063011-092449","article-title":"Nanobodies Natural Single-Domain Antibodies","volume":"82","author":"Muyldermans","year":"2013","journal-title":"Annu Rev Biochem"},{"key":"2026102305073254200_cit11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s40259-019-00392-z","article-title":"The Therapeutic Potential of Nanobodies","volume":"34","author":"Jovc\u030cevska","year":"2020","journal-title":"BioDrugs"},{"key":"2026102305073254200_cit12","doi-asserted-by":"publisher","first-page":"5639","DOI":"10.3390\/cancers15235639","article-title":"Small Antibodies with Big Applications: Nanobody-Based Cancer Diagnostics and Therapeutics","volume":"15","author":"Zhang","year":"2023","journal-title":"Cancers"},{"key":"2026102305073254200_cit13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2967\/jnumed.115.162024","article-title":"Phase I Study of 68Ga-HER2-Nanobody for PET\/CT Assessment of HER2 Expression in Breast Carcinoma","volume":"57","author":"Keyaerts","year":"2016","journal-title":"J Nucl Med"},{"key":"2026102305073254200_cit14","doi-asserted-by":"publisher","first-page":"5277","DOI":"10.1007\/s00259-026-07870-x","article-title":"Anti-HER2 nanobody 5F7-based theranostics using [68Ga]Ga-NOTA-5F7 PET\/CT and [131I]SGMIB-5F7 SPECT\/CT in HER2-positive breast cancer","volume":"53","author":"Wu","year":"2026","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026102305073254200_cit15","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13058-024-01803-y","article-title":"Detection of HER2 expression using 99mTc-NM-02 nanobody in patients with breast cancer: a non-randomized, non-blinded clinical trial","volume":"26","author":"Zhao","year":"2024","journal-title":"Breast Cancer Res"},{"key":"2026102305073254200_cit16","doi-asserted-by":"publisher","first-page":"12855","DOI":"10.1021\/acs.jmedchem.4c00857","article-title":"Imaging and Monitoring HER2 Expression in Tumors during HER2 Antibody\u2212Drug Conjugate Therapy Utilizing a Radiolabeled Site-Specific Single-Domain Antibody Probe: 68Ga-NODAGA-SNA004-GSC","volume":"67","author":"Ge","year":"2024","journal-title":"J Med Chem"},{"key":"2026102305073254200_cit17","doi-asserted-by":"publisher","first-page":"9757","DOI":"10.1021\/acs.jmedchem.6c00837","article-title":"Development and Preclinical Evaluation of a Novel 68Ga\/177Lu-Labeled Nanobody for Radiotheranostics of HER2-Positive Tumors","volume":"69","author":"Zhao","year":"2026","journal-title":"J Med Chem"},{"key":"2026102305073254200_cit18","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1021\/bc500111t","article-title":"Site-Specific Labeling of Cysteine-Tagged Camelid Single-Domain Antibody-Fragments for Use in Molecular Imaging","volume":"25","author":"Massa","year":"2014","journal-title":"Bioconjug Chem"},{"key":"2026102305073254200_cit19","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/j.drudis.2022.03.013","article-title":"Engineering nanobodies for next-generation molecular imaging","volume":"27","author":"Yang","year":"2022","journal-title":"Drug Discov Today"},{"key":"2026102305073254200_cit20","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.3390\/biom10101388","article-title":"Anti-Human PD-L1 Nanobody for Immuno-PET Imaging: Validation of a Conjugation Strategy for Clinical Translation","volume":"10","author":"Bridoux","year":"2020","journal-title":"Biomolecules"},{"key":"2026102305073254200_cit21","doi-asserted-by":"publisher","first-page":"7934","DOI":"10.1038\/s41598-018-26338-z","article-title":"The structural basis of nanobody unfolding reversibility and thermoresistance","volume":"8","author":"Kunz","year":"2018","journal-title":"Sci Rep"},{"key":"2026102305073254200_cit22","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1007\/s00216-019-01633-4","article-title":"Nanobody: outstanding features for diagnostic and therapeutic applications","volume":"411","author":"Salvador","year":"2019","journal-title":"Anal Bioanal Chem"},{"key":"2026102305073254200_cit23","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/1873-3468.15064","article-title":"Thermodynamic versus kinetic basis for the high conformational stability of nanobodies for therapeutic applications","volume":"599","author":"Go\u0301mez-Mulas","year":"2025","journal-title":"FEBS Lett"},{"key":"2026102305073254200_cit24","doi-asserted-by":"publisher","first-page":"138046","DOI":"10.1016\/j.ijbiomac.2024.138046","article-title":"The lack of trade-off between conformational stability and binding affinity in a nanobody with therapeutic potential for a misfolding disease","volume":"284","author":"Go\u0301mez-Mulas","year":"2025","journal-title":"Int J Biol Macromol"},{"key":"2026102305073254200_cit25","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1186\/s12951-024-02900-y","article-title":"Discovery of nanobodies: a comprehensive review of their applications and potential over the past five years","volume":"22","author":"Alexander","year":"2024","journal-title":"J Nanobiotechnology"},{"key":"2026102305073254200_cit26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jps.20727","article-title":"Antibody structure, instability, and formulation","volume":"96","author":"Wang","year":"2007","journal-title":"J Pharm Sci"},{"key":"2026102305073254200_cit27","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/cmmi.1606","article-title":"Gallium(III) complexes of NOTA-bis (phosphonate) conjugates as PET radiotracers for bone imaging","volume":"10","author":"Holub","year":"2015","journal-title":"Contrast Media Mol Imaging"},{"key":"2026102305073254200_cit28","doi-asserted-by":"publisher","first-page":"708","DOI":"10.7150\/thno.8156","article-title":"Targeted radionuclide therapy with A 177Lu-labeled anti-HER2 nanobody","volume":"4","author":"D\u2019Huyvetter","year":"2014","journal-title":"Theranostics"},{"key":"2026102305073254200_cit29","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1186\/s12951-025-03868-z","article-title":"A high-affinity CEA-targeted nanobody for 68Ga PET imaging and 177Lu-based radioisotope therapy: preclinical and first-in-human evaluation","volume":"23","author":"Zhang","year":"2025","journal-title":"J Nanobiotechnology"},{"key":"2026102305073254200_cit30","doi-asserted-by":"publisher","first-page":"332","DOI":"10.3390\/bios16060332","article-title":"SPR Sensing: From Biomolecular Interactions to Cell-Based Analysis","volume":"16","author":"Genova-Kalou","year":"2026","journal-title":"Biosensors"}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.6c02664","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/69\/20\/24827\/68811894\/jm6c02664.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/69\/20\/24827\/68811894\/jm6c02664.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T09:30:46Z","timestamp":1792747846000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/69\/20\/24827\/5448556\/Evaluation-of-68Ga-Labeling-Strategies-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,10]]},"references-count":30,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2026,10,10]]},"published-print":{"date-parts":[[2026,10,22]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.6c02664","relation":{},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,10]]}}}